Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
4.870
+0.190 (4.06%)
At close: Dec 20, 2024, 4:00 PM
4.760
-0.110 (-2.26%)
After-hours: Dec 20, 2024, 7:58 PM EST
Lipocine Market Cap
Lipocine has a market cap or net worth of $26.04 million as of December 20, 2024. Its market cap has increased by 88.73% in one year.
Market Cap
26.04M
Enterprise Value
6.37M
1-Year Change
88.73%
Ranking
Category
Stock Price
$4.87
Market Cap Chart
Since October 22, 2013, Lipocine's market cap has decreased from $35.00M to $26.04M, a decrease of -25.59%. That is a compound annual growth rate of -2.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 26.00M | 75.68% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -26.21% |
| Dec 31, 2013 | 91.20M | 160.57% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 25.83M |
| HOOKIPA Pharma | 25.80M |
| Gelteq | 25.67M |
| DarioHealth | 25.23M |
| Femasys | 25.19M |
| NeuroSense Therapeutics | 24.92M |
| Akari Therapeutics, | 24.76M |
| Pluri | 24.46M |